Compare BLCO & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | DOX |
|---|---|---|
| Founded | 1853 | 1982 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.5B |
| IPO Year | 2022 | 1998 |
| Metric | BLCO | DOX |
|---|---|---|
| Price | $16.25 | $51.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $18.45 | ★ $92.33 |
| AVG Volume (30 Days) | 344.9K | ★ 1.7M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $8.65 | $4.48 |
| Revenue Next Year | $5.59 | $3.76 |
| P/E Ratio | ★ N/A | $13.65 |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $13.09 | $49.80 |
| 52 Week High | $18.92 | $90.29 |
| Indicator | BLCO | DOX |
|---|---|---|
| Relative Strength Index (RSI) | 51.33 | 39.30 |
| Support Level | $15.36 | $49.80 |
| Resistance Level | $16.54 | $67.82 |
| Average True Range (ATR) | 0.48 | 1.51 |
| MACD | 0.07 | 0.37 |
| Stochastic Oscillator | 52.59 | 59.51 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.